Table 1 Clinical characteristics of patients in this study.

From: Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours

Sample ID

Gender

Age (years)

Morphology

Surgical stage

Overall stage

Site of metastasis, if any

CMCW1

M

5.1

Diffuse anaplasia

1

4

Lung

CMCW3

M

2.0

FH

3

3

Adrenal

CMCW5

M

9.1

FH

3

4

Lung

CMCW7

F

3.7

FH

2

2

 

CMCW9

F

1.5

FH

2

2

 

CMCW11

F

5.2

Diffuse anaplasia

3

4

Lymph node, rib, lung

CMCW13

F

2.9

FH

3

3

 

CMCW15

F

5.1

FH

3

4

Lung

CMCW17

M

4.2

FH

2

2

 

CMCW19

M

2.5

FH

3

3

Lymph node

CMCW21

F

0.9

FH

1

1

 

CMCW23

M

3.5

Diffuse anaplasia

2

2

 

CMCW25

M

2.8

FH

3

3

 

CMCW27

F

3.4

FH

2

4

Lung

CMCW29

F

7.9

FH

1

1

 

CMCW31

M

0.8

FH

1

1

 

CMCW33

F

2.9

FH

2

2

 

CMCW35

F

4.2

FH

1

1

 

CMCW37

F

3.7

FH

2

2

 

CMCW39

M

1.7

FH

2

2

 

CMCW41

M

4.3

FH

2

5

 

CMCW43

F

4.7

Focal anaplasia

3

3

 

CMCW45

M

7.2

FH

3

4

Lung

CMCW47

M

3.4

FH

2

2

 

CMCW49

M

2.5

FH

2

2

 

CMCW51

M

0.8

FH

3

3

 

CMCW53

M

8.3

FH

3

4

Lung

CMCW57

M

0.9

FH

3

3

 

CMCW59

M

3.5

Diffuse anaplasia

3

3

 

CMCW61

F

1.2

FH

2

2

 

CMCW63

M

1.4

FH

3

3

 

CMCW65

F

2.3

FH

1

1

 

CMCW67

M

1.6

FH

2

2

 

CMCW69

F

0.7

FH

3

3

 

CMCW71

M

2.7

FH

3

3

 

CMCW75

F

5.2

FH

3

4

Lung

CMCW77

M

1.3

FH

1

1

 

CMCW79

F

3.3

FH

2

4

Lung

CMCW81

F

2.6

FH

2

2

 

CMCW83

F

8.0

FH

3

4

Lung, liver

CMCW85

M

2.3

FH

2

4

Lung

CMCW87

F

1.2

FH

1

1

 

CMCW89

F

6.7

FH

3

4

Heart/lung

CMCW91

M

3.5

FH

3

3

 
  1. F, female; FH, favourable histology; M, male.
  2. CMCW1-CMCW29 represent tumours in the discovery set; CMCW31-CMCW91 represent tumours in the validation set.